D.A. Davidson & Co. Acadia Pharmaceuticals Inc Transaction History

D.A. Davidson & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$14.32 - $22.92 $279,941 - $448,063	-19,549 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$13.03 - $21.81 $173,299 - $290,073	-13,300 Reduced 40.49%	19,549 $406,000
Q2 2018 Aug 02, 2018	BUY	$15.07 - $22.34 $47,470 - $70,371	3,150 Added 10.61%	32,849 $502,000
Q1 2018 May 04, 2018	BUY	$22.47 - $32.33 $2,247 - $3,233	100 Added 0.34%	29,699 $667,000
Q4 2017 Feb 08, 2018	BUY	$26.84 - $39.14 $40,474 - $59,023	1,508 Added 5.37%	29,599 $891,000

Q3 2017 Nov 08, 2017	BUY	$29.49 - $38.37 $26,541 - $34,533	900 Added 3.31%	28,091 $1.06 Million
Q2 2017 Aug 11, 2017	BUY	N/A	27,191	27,191 $0

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.